Significance of HBV DNA in the hepatic parenchyma from patients with non-B, non-C hepatocellular carcinoma

World Journal of Surgery

Volumn 30, Issue 7, 2006, Pages 1338-1343

  Nakai, Takuya ^a   Shiraishi, Osamu ^a   Kawabe, Takashi ^a   Ota, Hideo ^b   Nagano, Hiroaki ^b   Shiozaki, Hitoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DNA DETERMINATION; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVER CELL; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL RATE; VIRUS EXAMINATION;

CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B VIRUS; HUMANS; IN SITU HYBRIDIZATION; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RNA, VIRAL; SURVIVAL RATE;

EID: 33746085579     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-0318-0     Document Type: Article

References (24)

1. Shiratori Y, Shiina S, Imamura M, et al. Characteristic difference of hepatocellular carcinoma between hepatitis B and C viral infection in Japan. Hepatology 1995;22:1027-1033.
2. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis to C virus. Hepatology 1990;12:671-675.
3. Takaguchi K, Satou A, Ando M, et al. Detection of hepatitis B virus DNA in the liver and serum of patients with hepatitis B surface antigen and hepatitis C virus antibody negative chronic liver disease. Hepatol Res 2002;22:139-144.
4. Kazemi-Shirazi L, Petermann D, Muller C. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C. J Hepatol 2000;33:785-790.
5. Nakai T, Koh K, Kawabe T, et al. Clinical characteristics of hepatitis B core antibody-positive hepatocellular carcinoma. World J Surg 2002;26:700-703.
6. Uemoto S, Sugiyama K, Marusawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998;65:494-499.
7. Chazouilleres O, Mamish D, Kim M, et al. "Occult" hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994;343:142-146.
8. Caballero T, Caballero MA, Ruiz-Extremera A, et al. Detection of hepatitis B virus in the liver by in situ hybridization (ISH) in HBsAg seropositive and seronegative patients. Histol Histopathol 1995;10:265-270.
9. Felgar RE, Montone KT, Furth EE. A rapid method for the detection of hepatitis C virus RNA by in situ hybridization. Mod Pathol 1996;9:696-702.
10. Tay N, Chan SH, Ren EC. Detection of integrated hepatitis B virus DNA in hepatocellular carcinoma cell lines by non-radioactive in situ hybridization. J Med Virol 1990;30:266-271.
11. Shin YJ, Cho SW, Hahm KB, et al. Localization of hepatitis B virus DNA in hepatocellular carcinoma by polymerase chain reaction in situ hybridization. J Korean Med Sci 1998;13:377-382.
12. Tsutsumi M, Ishizaki M, Takada A. Relative risk for the development of hepatocellular carcinoma in alcoholic patients with cirrhosis: a multiple logistic-regression coefficient analysis. Alcohol Clin Exp Res 1996;20:758-762.
13. Tsukuma H, Hiyama T, Tanaka S, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797-1801.
14. Bagnardi V, Blangiardo M, La Vecchia C, et al. A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 2001;85:1700-1705.
15. Marrero JA, Fontana RJ, Su GL, et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002;36:1349-1354.
16. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-140.
17. Higashi Y, Tada S, Miyase S, et al. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients. Liver 2002;22:374-379.
18. Yotsuyanagi H, Shintani Y, Moriya K, et al. Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus. J Infect Dis 2000;181:1920-1928.
19. Ohkoshi S. Detection of HBV DNA in non-A, non-B hepatic tissues using the polymerase chain reaction assay. Gastroenterol Jpn 1991;26:728-733.
20. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinoma: a retrospective and nationwide survey in Japan. Hepatology 2000;32:1224-1229.
21. Ikai I, Arii S, Kojiro M, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 2004;101:796-802.
22. Yamanaka N, Tanaka T, Tanaka W, et al. Correlation of hepatitis virus serologic status with clinicopathologic features in patients undergoing hepatectomy for hepatocellular carcinoma. Cancer 1997;79:1509-1515.
23. Sakon M, Umeshita K, Nagano H, et al. Clinical significance of hepatic resection in hepatocellular carcinoma analysis by disease-free survival curves. Arch Surg 2000;135:1456-1459.
24. Ikeda K, Arase Y, Kobayashi M, et al. Consistently low hepatitis B virus DNA saves patients from hepatocellular carcinogenesis in HBV-related cirrhosis: a nested case-control study using 96 untreated patients. Intervirology 2003;46:96-104.